BIODIAL spol. s r.o.

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease5 trials
• High blood pressure2 trials

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• AstraZeneca3 trials
• Bayer1 trial
• Genexine Inc.1 trial

Running trials

• Recruiting

  Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis

  2023-503634-50-01· Phase 3· Genexine Inc.· Source

• Recruiting

  A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  NCT06742723· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

  NCT06268873· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

  NCT06087835· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• High blood pressure1 recruiting

Closed trials

• Completed

  A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

  NCT06522997· Phase 2· Bayer· Source